Literature DB >> 2752163

Long-term follow-up study of children with chronic ITP.

J Akatsuka1, K Fujisawa, N Ishidoya, N Taguchi, I Tsukimoto, G Tsujino, T Nagao, T Nakahata, S Miyazaki, T Takeda.   

Abstract

A total of 126 children with chronic idiopathic thrombocytopenic purpura, including 35 splenectomized cases, were investigated in a long-term follow-up study, with regard to residual hematologic and immunologic abnormalities, complications and physical growth. Such hemorrhagic symptoms as petechiae, ecchymosis and epistaxis were still observed in about 22%-28% of the patients with a period of morbidity ranging from 3 to 15 years after onset. Residual thrombocytopenia below 150,000/microliters was found in 62% of patients within 5 years, 59% within 5 to 9 years and 57% within 10-14 years after onset. Other abnormalities were mild anemia, low serum level of IgA or IgM, positive antinuclear antibody, rheumatoid factor, and positive Coombs test in a small number of patients. Increased platelet-associated IgG was still obtained in patients with subnormal platelet counts whose morbid periods were 6 to 27 years after onset. Investigation of the patients by questionnaire revealed such complications as obesity, striae atrophicae, abdominal pain, headache, cataract, Perthes' disease, and cardiac complication in some patients. No apparent disturbances except for obesity were observed in their physical growth.

Entities:  

Mesh:

Year:  1989        PMID: 2752163     DOI: 10.1007/bf00320258

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  9 in total

1.  Clinical significance of positive platelet immunofluorescence test in thrombocytopenia.

Authors:  A E von dem Borne; J J Vos; J van der Lelie; B Bossers; C M van Dalen
Journal:  Br J Haematol       Date:  1986-12       Impact factor: 6.998

2.  Flow cytometric measurement of antiplatelet antibodies.

Authors:  C S Rosenfeld; G Nichols; D C Bodensteiner
Journal:  Am J Clin Pathol       Date:  1987-04       Impact factor: 2.493

3.  Idiopathic thrombocytopenic purpura: an epidemiologic study.

Authors:  A T Lammi; V A Lovric
Journal:  J Pediatr       Date:  1973-07       Impact factor: 4.406

4.  Platelet-associated IgG assay using flow cytometric analysis.

Authors:  J Lazarchick; S A Hall
Journal:  J Immunol Methods       Date:  1986-03-13       Impact factor: 2.303

5.  T-cell-subset characterization of human T-CLL.

Authors:  E L Reinherz; L M Nadler; D S Rosenthal; W C Moloney; S F Schlossman
Journal:  Blood       Date:  1979-06       Impact factor: 22.113

6.  The thrombocytopenic effect of sustained high-dosage prednisone therapy in thrombocytopenic purpura.

Authors:  P COHEN; F H GARDNER
Journal:  N Engl J Med       Date:  1961-09-28       Impact factor: 91.245

7.  Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura.

Authors:  S J Woerner; C F Abildgaard; B N French
Journal:  Pediatrics       Date:  1981-04       Impact factor: 7.124

8.  Idiopathic thrombocytopenia, initial illness and long term follow up.

Authors:  R W Walker; W Walker
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

Review 9.  Immune thrombocytopenia in children.

Authors:  M Karpatkin; S Karpatkin
Journal:  Am J Pediatr Hematol Oncol       Date:  1981
  9 in total
  1 in total

Review 1.  Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity.

Authors:  P Imbach; J Akatsuka; V Blanchette; A Burek-Kozlowska; J Bussel; G Gaedicke; A Gianella-Borradori; E Gugler; A Hirt; B Imholz
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.